Significant correlation between ctDNA levels and tumor burden in anti-PD1-treated patients with various cancersSignificant correlation between ctDNA and tumor burden in HCC patients treated with atezolizumab plus bevacizumab. This evidence concerns the gene PDCD1 and neoplasm.